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Abstract
MicroRNAs (miRNAs) are post-transcriptional regulators that bind to their target mRNAs through base complementarity.
Predicting miRNA targets is a challenging task and various studies showed that existing algorithms suffer from high number
of false predictions and low to moderate overlap in their predictions. Until recently, very few algorithms considered the
dynamic nature of the interactions, including the effect of less specific interactions, the miRNA expression level, and the
effect of combinatorial miRNA binding. Addressing these issues can result in a more accurate miRNA:mRNA modeling with
many applications, including efficient miRNA-related SNP evaluation. We present a novel thermodynamic model based on
the Fermi-Dirac equation that incorporates miRNA expression in the prediction of target occupancy and we show that it
improves the performance of two popular single miRNA target finders. Modeling combinatorial miRNA targeting is a natural
extension of this model. Two other algorithms show improved prediction efficiency when combinatorial binding models
were considered. ComiR (Combinatorial miRNA targeting), a novel algorithm we developed, incorporates the improved
predictions of the four target finders into a single probabilistic score using ensemble learning. Combining target scores of
multiple miRNAs using ComiR improves predictions over the naı¨ve method for target combination. ComiR scoring scheme
can be used for identification of SNPs affecting miRNA binding. As proof of principle, ComiR identified rs17737058 as
disruptive to the miR-488-5p:NCOA1 interaction, which we confirmed in vitro. We also found rs17737058 to be significantly
associated with decreased bone mineral density (BMD) in two independent cohorts indicating that the miR-488-5p/NCOA1
regulatory axis is likely critical in maintaining BMD in women. With increasing availability of comprehensive high-
throughput datasets from patients ComiR is expected to become an essential tool for miRNA-related studies.
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Introduction
MicroRNAs (miRNAs) belong to a class of short (18–25
nucleotide) non-coding RNAs that regulate gene expression post-
transcriptionally. Their regulatory activity depends heavily on the
recognition of target sites located primarily on the 39-untranslated
regions (39UTRs) of messenger RNAs [1] but also on ORFs or 59-
UTRs [2]. In general, a gene contains multiple miRNA binding
sites. Computational miRNA target prediction depends on
algorithms that typically use features like Watson–Crick base pair
matching [3–5], thermostability of binding sites [3,6–12], acces-
sibility of target sites [3,13], and phylogenetic conservation [3,5].
Still, target prediction algorithms suffer from high number of false
predictions and poor overlap in their predictions [14,15]. It is
worth noting that most existing algorithms only utilize site-specific
features [16] ignoring factors like the relative expression of
miRNAs that affects binding specificity and target combinatorial
effects. The level of miRNA expression affects which targets will be
occupied. When a miRNA is expressed at low levels it is expected
to bind to only few, high affinity targets. As miRNA expression is
increased, and all high affinity targets are occupied, the remaining
miRNA molecules can bind to suboptimal targets of moderate
affinity (due to target exclusivity). We believe that the 1:1
stoichiometric binding model used by existing algorithms may be
insufficient for the dynamic nature of real miRNA:mRNA
interactions. This may be a major drawback of the current target
prediction algorithms. Another drawback of most algorithms is
that they only consider single miRNA:mRNA pairings, ignoring
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the fact that multiple miRNAs, each with a moderate effect, can
collectively alter significantly the expression levels of a given
mRNA. Extending single pairing predictions to the union or
intersection of targets of multiple miRNAs does not solve this
problem since these models do not consider multiple moderate
binding effects and they also tend to be either very conservative or
having large numbers of false positive predictions, respectively.
Until recently, the only notable exceptions were PicTar [10] and
GenMir++ [17]. PicTar uses a hidden Markov model to determine
targets of multiple miRNAs, but it does not consider the miRNA
expression in determining the relative binding. GenMir++
implements an elaborate Bayesian framework to model miR-
NA:mRNA dependencies using expression data and prior
targeting information. The prior information is provided in binary
form (putative targets/non-targets) and the effect of multiple
miRNAs on a given mRNA is inferred using an expectation
maximization (EM) algorithm. TaLasso [18], a recently published
algorithm, combines miRNA expression with prior database
information to infer regulation of mRNAs from a set of miRNAs
using a lasso regression method to determine the activities of
various miRNAs. Finally, Jayaswal et al. [19] proposed another
method for finding multiple (many-to-many) miRNA:mRNA
interactions by following a two-step approach. First, they identify
miRNA and mRNA expression clusters and in the second step
they find associations between them. In this case, there is no
quantitative modeling of particular interactions. These algorithms
have in common that they use miRNA expression to drive the
target prediction for sets of miRNAs, but none of them has an
underlying suitable thermodynamic model to account for target
exclusivity. Furthermore, none of these algorithms has been used
before to quantitatively rank single nucleotide polymorphisms
(SNPs) affecting miRNA targeting. In general, so far, the
evaluation of miRNA-related SNPs in disease has been done with
more straightforward approaches [20,21].
Until recently, a major obstacle for developing comprehensive
miRNA binding models was the small number of available
experimentally validated target pairs. This is now changing with
the development of new experimental approaches that promise to
generate validated miRNA:mRNA target data in a high-through-
put fashion. One such technique is based on immunoprecipitation
(IP) of miRISC proteins (RNA-induced silencing complex) [22],
which probes the abundance of target mRNA bound to a mature
miRNA. Although the actual miRNA:target pairs are not
determined by this technique, the analysis of such datasets
combined with the relative abundance of mRNAs and miRNAs
[23] is critical for understanding the true cooperative interactions
and model them in a quantitative way. Crosslinking immunopre-
cipitation (CLIP) is another recently developed and promising
method. Both HITS-CLIP [24] and PAR-CLIP [25] allow for the
miRNA target region to be determined in a narrow window on the
mRNA. The high-throughput datasets these methods provide are
ideal for developing methods to help a better understanding of the
miRNA:mRNA targeting process.
This paper addresses various issues related to miRNA targeting.
First, we show that miRNA targets generally act additively in
regulating mRNA expression. This was previously postulated but –
to our knowledge– never put in test. Second, we show that using
miRNA expression to appropriately weigh miRNA targets can
result in efficient additive combinatorial models. To that extent we
develop a novel thermodynamic model for miRNA binding, based
on the Fermi-Dirac equation and we show that using this model
improves prediction accuracy and target overlap of PITA [26] and
miRanda [27]. Prediction efficiency of TargetScan [28] and
mirSVR [29] is also improved by weighting multiple miRNA
targets by miRNA expression and combining their target scores
additively. Third, we use a Support Vector Machine (SVM) to
combine the improved predictions of these four algorithms in
ComiR (Combinatorial miRNA targeting), our novel algorithm
that is designed to address the question of how likely is for a set of
miRNAs with known expression levels to influence the expression
of a given mRNA. The algorithm is tested on previously published
miRISC protein IP independent datasets, ranging over three
species, D. melanogaster, C. elegans and H. sapiens. Finally, we show
that ComiR scoring scheme is suitable for ranking SNPs affecting
miRNA binding. As a proof of principle, we used ComiR scoring
for ranking the genes of the estrogen receptor (ER) pathway and
we predicted that SNP rs17737058 would disrupt a miR-488-5p
binding site in NCOA1. We subsequently confirmed the
interaction in vitro and we found the SNP to be associated with
decreased bone mineral density in two independent datasets.
These results illustrate the predictive power of ComiR and that
rs17737058 should be further studied as a risk factor for
osteoporosis. This is an important ComiR application, since
identifying functional DNA sequence variants will be critical in the
era where plentiful information will become readily available for
many diseases.
Results
Evidence for additivity in miRNA targeting
First, we examined whether cooperativity is an important factor
in miRNA targeting. Let-7d, miR-30b and scrambled miRNA
were transfected into human fetal lung fibroblast and microarray
analysis was performed. Log2 of fold change (FC) in transcript
abundance was measured with respect to scrambled miRNA
transfection after let-7d transfection (FCl), miR-30b transfection
(FCm) or let-7d/miR-30b co-transfection (FClm). Differentially
expressed mRNAs were identified with SAM analysis (qval,0.05)
in each of the three experiments. In particular, 1,413 genes were
significantly down-regulated post let-7d transfection (746 of them
were only down-regulated in the let-7d transfection), 1,819 post
miR-30b transfection (966 of them were only down-regulated in
the miR-30b transfection) and 1,039 after both miRNAs were
transfected. The 132 out of the 1,039 down-regulated genes were
identified only in the co-transfection experiment, indicating that
these were targets on which miRNAs act co-operatively. We used
stepwise regression to test the potential miRNA additive effect on
Author Summary
MicroRNA genes (miRNAs) are small non-coding RNAs that
regulate the expression levels of mRNAs post-transcrip-
tionally. miRNAs are critical in many important biological
processes, like development, and are important markers
for many diseases. Identifying the targets of miRNAs is not
an easy task. Recent developments of high-throughput
data collection methods for identification of all miRNA
targets in a cell are promising, but they still depend on
computational algorithms to identify the exact miR-
NA:mRNA interactions. In this paper we present a novel
algorithm, ComiR, which addresses a more general
question, that is, whether a given mRNA is targeted by a
set of miRNAs. ComiR uses miRNA expression to improve
the targeting models of four target prediction algorithms.
Then it combines their predicted targets using a support
vector machine. By applying ComiR to single nucleotide
polymorphism (SNP) data, we identified a SNP that is likely
to be causally associated to osteoporosis in women.
ComiR: Combinatorial Modeling of miRNA Targeting
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the fold change of the target genes. Our model is:
FClm~=za1:FCmza2:FClza3:FCl :FCm
where = is the intercept. We performed a backward elimination by
eliminating the less significant variables. The elimination of the
variable from the regression model always causes a decrease of the
resulting R2 value of the regressions. We found that the let-7d and
miR-30b mRNA interactions are additive for most genes: small
decrease of the R2 value was observed when the cross product
term was eliminated (from 67.1% to 67.05%; both p-val,10215).
However, when the regression model was applied to the subset of
the 132 genes that were found to be significantly down-regulated
only in the co-transfection experiment, then elimination of the
cross product term significantly impacts the R2 value (p-value
changes from 1023 to 0.06). Notably, all weights obtained were
,1, which probably reflects the saturation and competition effects
on the miRISC machinery by the transfections [30]. The complete
list of the regression coefficients is provided in Table S1.
Figure S1 presents the distribution of binding sites for the genes
that were down-regulated in the single transfection experiments
only (red and yellow bars), in all three experiments (green bars)
and in the co-transfection experiment only (black bars). We see
that in all but the last category a higher percentage of genes has
few (1 or 2) binding sites, whereas for the genes were co-operativity
was observed had generally more sites (4 or 7). This indicates that
co-operativity may be more important when a large number of
sites is present in a gene.
Incorporating miRNA expression improves prediction
efficiency of multiple targets
Considering miRNA expression in the thermodynamic
binding model. The thermodynamic model employed for
miRNA:mRNA interactions in algorithms like PITA [26] and
miRanda [27] assumes that binding occurs between a single
miRNA and a single target in equilibrium. We developed a novel
thermodynamic model based on the Fermi-Dirac (FD) equations,
which takes into account both binding affinity and miRNA
expression in determining the binding potential. The idea is
similar to previous successful modeling of transcription factor
binding activities performed by one of us [31] and others [32].
Suppose that miRNA i (miRi) has nik binding sites BSijk
(j = 1,…,nik) on mRNA k. The reversible reaction of binding of
miRi to the particular binding site BSijk is:
miRizBSijk'miRi : BSijk
The equilibrium binding constant of the miRi to the binding site
BSijk is:
Ki~
½miRi : BSijk
½miRi½BSijk
The probability of BSijk to be bound by miRi is:
P(miRi : BSijk)~
½miRi : BSijk
½miRi : BSijkz½BSijk~
1
1z
1
Ki½miRi
~
1
1ze
(Eijk{m)=RT
ð1Þ
where Eijk =2RTN ln(Ki) is the standard free energy of binding
and m= RT N ln([miRi]). The probabilistic score of Eq. 1 gives a
natural way to combine the effect of multiple targets (from the
same or multiple miRNA genes) on a given gene.
FD score : Sk~
XN
i~1
Xnik
j~1
P(miRi : BSijk) ð2Þ
For the gene k the FD score is the sum of probabilities over all
binding sites (nik) and all the considered miRNAs (N). In Eq. 1, as
Eijk we can use the energy score provided by PITA or miRanda
(typically negative values) and [miRi] is the concentration of
miRNA i. As an estimate of the miRNA concentration in this
paper we use its expression level. In this way, the binding sites with
very negative energies and high expression level give the major
contribution to the combined score. We call this method
weighted score method to distinguish it from the naı¨ve
method, according to which a gene is predicted to be a target of
the miRNA set if it is a target of at least one of the miRNAs in the
set. We compared the FD model to the naı¨ve method on PITA
and miRanda predictions of the targets of the 28 miRNAs in the
Ago1-IP positive Drosophila dataset (see Materials and Methods).
For both the naı¨ve and the weighted score method, we considered
the predicted genes associated with the top 10% of scores of each
tool (i.e. ,1100 genes) as targets. Although miRanda and PITA
use related thermodynamic models, their overlap is poor
(Figure 1A), reaching only 38% of the total predicted targets.
When the FD model (Eq. 2) was used, the overlap was
substantially improved, reaching 82% (Figure 1B). Using the
positive and negative datasets (see Materials and Methods), we
calculated the ROC curves of the performance of the two methods
(Figure 1C) and we found that both sensitivity and specificity
improves substantially with the use of the FD model for score
combination. The AUC was improved by 18% and 16% in the
case of PITA and miRanda, respectively.
Considering miRNA expression in other target prediction
methods. Not all the target prediction algorithms use a
thermodynamic model. TargetScan [28] for example uses a
simple n-mer match and mirSVR [29] combines predictions of
individual miRNA:mRNA targets from multiple algorithms using
support vector regression. For these algorithms, miRNA expres-
sion can be used to weigh the score of target combinations
(weighted sum score or WSUM) using Eq. 3:
WSUM score : Sk~
XN
i~1
Sik:½miRi ð3Þ
where we sum the target scores Sik detected for each miRNA,
weighted by the relative expression level of the miRNA.
Considering miRNA expression through Eq. 3 when combining
miRNA targets improves the performance of TargetScan and
mirSVR, although the improvement in this case is moderate
(TargetScan AUC: 0.82 (WSUM) vs. 0.79 (naı¨ve); mirSVR AUC:
0.82 (WSUM) vs. 0.80 (naı¨ve)). In any case, these results show that
regardless of the magnitude, incorporation of miRNA expression
when combining targets of multiple miRNAs improves prediction
efficiency of all four methods.
ComiR: Integration of multiple prediction algorithms and
miRNA expression data
Based on the previous results, we developed ComiR (Combi-
natorial miRNA targeting), a novel algorithm that integrates the
ComiR: Combinatorial Modeling of miRNA Targeting
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predictions of four top target prediction tools: PITA [26],
miRanda [27], TargetScan [28] and mirSVR [29], into a single
score. See Text S1 for more details about the implementation of
the existing target prediction tools. First, each algorithm is run
separately and for a given mRNA we identify all binding sites of
each miRNA in its 39UTR. Then, we incorporate miRNA
expression and we additively combine the individual target scores
using either Eq. 2 in the cases of PITA and miRanda (FD score),
or Eq. 3 in the cases of TargetScan and mirSVR (WSUM score).
By considering the miRNA expression in target score integration
(Eq. 2 and Eq. 3) ComiR improves the efficiency of the
corresponding algorithms as we showed above. The scores of the
four tools for each mRNA are then combined through an SVM
with linear kernel trained on the Drosophila RISC IP dataset [22]
(see Materials and Methods). The target prediction score of
ComiR is the class probability value computed by using the
trained SVM model. Hence, ComiR scores range from 0 to 1 and
higher scores correspond to higher probability of an mRNA being
a functional target of the particular set of miRNAs. For the SVM
implementation we used the ‘e1071’ R library. The general
framework of ComiR is presented in Figure 2. The normalization
step is a cross-species normalization of the score distributions (see
Text S1 and Figure S2).
ComiR outperforms existing algorithms within and across
species
ComiR training and testing in Drosophila AGO1 IP
datasets. ComiR was trained on the balanced Drosophila
RISC IP dataset derived from [22], as we describe in Materials
and Methods. In order to assess whether ComiR offers an
improvement over the standard methods, we applied it to two
Drosophila-derived datasets as well as independent datasets from
C. elegans and humans. For the Drosophila, we first performed a
self-test, which –as expected– showed ComiR to perform better
than all other algorithms (Figure 3A; AUC = 0.85 compared to a
low value of 0.69 for miRanda and a high value of 0.81 for
mirSVR). Using the pROC package [33] we found that this
difference was statistically significant for miRanda (p-value = 1025)
and PITA (p-value = 1023). We also performed the leave-one-out-
cross-validation (LOOCV) on this dataset with similar results
(Figure S3A). Then we tested ComiR on a separate Drosophila
dataset that was not used for training. This set consisted of Set III
as positive examples and those Set IV genes that were not used for
training as negative examples. Since none of these mRNAs was
used in training, we consider this to be an external validation on a
dataset from the same species. Interestingly, we found that all
algorithms performed slightly worse, which might reflect to the less
stringent conditions this set was derived from. Still, ComiR
outperformed the other four algorithms with an AUC value that
was 12–17% better (Figure 3B; AUC = 0.74 compared to a low
value of 0.64 for miRanda and a high value of 0.66 for mirSVR).
In the external Drosophila dataset, ComiR performance was
statistically significantly higher compared to all four tools (p-values
from 1028 to 10216).
Drosophila-trained ComiR predicting C. elegans
targets. The C. elegans test data set includes a list of 49 miRNAs
with known expression and two sets of mRNAs that are IP
enriched with AIN1 and/or AIN2 proteins. We considered the
568 genes enriched in both AIN1 and AIN2 IP experiments as
true targets (positive dataset), but in this case there is no suitable
negative dataset. The Drosophila-trained ComiR was used to
predict the targets of the 49 C. elegans miRNAs. Given a specific
threshold, we compare the total number of genes predicted as
functional targets in the whole set with the number of genes
predicted as functional targets within the test set only. The
enrichment of predicted genes in the test set is statistically
significant, with a p-value lower than 10216. We compared the
results obtained with the naı¨ve generalization of the other existing
tools. Since we have no suitable negative examples in this dataset,
we cannot calculate a proper ROC curve (nor a p-value). Thus, in
Figure 3C we plot the percent of predicted targets versus the
threshold and we calculate the AUC although we note that this is
not a standard ROC curve. We observe that ComiR performs
always better than the other four algorithms on the C. elegans IP
enriched mRNA dataset. Out of the 49 miRNAs contained in this
test set, only one (miR-79) was included in the Drosophila training
set. Exclusion of this miRNA from the worm test set did not alter
the results (data not shown).
Drosophila-trained ComiR predicting H. sapiens PAR-
CLIP targets. PAR-CLIP [25] and HITS-CLIP [24] methods
can provide useful datasets for testing the efficiency of our
algorithm. In our analysis we considered the 27 most highly
expressed miRNAs, which had been simultaneously blocked in the
human PAR-CLIP experiment [25]. Furthermore, we assess the
efficiency of target prediction tools by comparing the change in
transcript’s abundance, or fold change, with the target prediction
tool’s scores, under the hypothesis that functional targets of the 27
miRNAs are the ones with the highest change of decreasing
Figure 1. The effect of Fermi-Dirac model in miRNA target
prediction. (A) Overlap of predicted targets from PITA and miRanda
using a naı¨ve combination of energy scores. (B) Target overlap between
PITA and miRanda using the Fermi-Dirac energy score combination. (C)
Receiver-operating Characteristic (ROC) curves of PITA and miRanda
predictions with naı¨ve (solid lines) and Fermi-Dirac (broken lines)
energy score combination. AUC: area under the curve. Positive and
negative sets were derived from the Ago1 IP data (Materials and
Methods).
doi:10.1371/journal.pcbi.1002830.g001
ComiR: Combinatorial Modeling of miRNA Targeting
PLOS Computational Biology | www.ploscompbiol.org 4 December 2012 | Volume 8 | Issue 12 | e1002830
transcript’s abundance. None of these miRNAs was included in
the Drosophila training dataset, thus the PAR-CLIP is another
independent test set. First, we tested how the target prediction
tools perform when the binding site search in the 39UTRs is
restricted on the Crosslink-Centered Regions (CCRs, see Material
and Methods). Restricting the search region offers a considerable
advantage to all prediction algorithms. ROC analysis showed that
the Drosophila-trained ComiR model performs 22–35% better
than the other target prediction tools in detecting human
functional targets (Figure 3D; AUC = 0.89 compared to a low
value of 0.66 for TargetScan and a high value of 0.73 for
mirSVR). In the case of the human PAR-CLIP dataset, ComiR
performed statistically significantly better compared to all four
tools (p-values 10216 for all algorithms). Unlike the other species
where TargetScan returns a binary answer (without considering
evolutionary conservation), for human data it provides a ‘‘context
score’’, which we used to plot a continuous ROC curve (Figure
S3B). The plot showed that TargetScan context score provides a
superior measure for collective target predictions over all other
algorithms except ComiR. In fact, the AUC for ComiR was still
9.5% larger than that of TargetScan (p-value = 10212). For
completeness of the analysis, the precision-recall curves of the
two Drosophila and the human datasets are presented in Figure
S4. To perform the precision-recall curves we used the ‘ROCR’ R
library [34].
Next, we considered the complete sequences of the 39UTR,
which is a broader but more commonly used dataset. In Figure S5,
we report the empirical cumulative distribution function (ecdf) of
the change in expression of the mRNAs after blocking the top 27
miRNAs. Genes containing at least one CCR in their 39UTR
sequence are grouped in deciles with respect to their target
prediction score. In case of TargetScan, genes are grouped in two
groups, predicted targets and predicted non-targets. We compare
the ecdf of change in expression of mRNAs containing CCRs
(colored lines) with the ecdf of mRNAs without CCRs (black line),
by using the two-sample Kolmogorov-Smirnov (KS) distance and
the Wilkoxon (W) rank test. The results are presented in Table S2.
We observe that mRNAs with higher target prediction scores (1st
deciles) are always the farthest with respect to the reference
distribution (Figure S5, black line and D values of the KS test
(dKS) in Table S2), meaning that computational prediction tools
are able to distinguish the functional targets. A comparison of the
reference distribution of scores with the KS distances and the
means of the ecdfs of the lower deciles shows that ComiR
(normalized by rank) outperforms all the other considered tools
(Table S2).
Drosophila-trained ComiR predicting miRNA
transfection results in human lung fibroblasts. We run
ComiR on the down-regulated genes resulting from the let-7d and
miR-30b transfection and co-transfection experiments. Table S3
shows that for the top 20%, 25% and 30% of the predicted targets
of each of the four tools, ComiR is generally more sensitive but less
specific than each of them. mirSVR on the other hand is the most
specific but the least sensitive in all cases. However, transfection
experiments do not yield optimal datasets for testing miRNA
target prediction, because of the severe perturbations they cause in
the cell [30]. In such cases, miRNA-mediated gene regulation is
not based solely on the miRNA:target binding energy, but also on
the competition for the introduced and endogenous miRNAs for
the available AGO proteins in the cell.
Inclusion of miRNA expression drives the improvement in
target prediction
ComiR is a multi-step algorithm that calculates the probability
of an mRNA being targeted by a set of miRNA genes. First,
depending on the prediction tool, it uses the FD score (Eq. 2) or
the WSUM score (Eq. 3) to incorporate the expression of each
miRNA and to combine the scores of individual targets of the
miRNA set in a single score. The FD score combination is used
when the primary target finding tool is either miRanda or PITA
(where binding energies are used for the scoring); whereas the
WSUM score combination is used for TargetScan or mirSVR.
Subsequently, an SVM is used to incorporate the prediction scores
of the four individual tools into a single probabilistic score
characteristic of the probability that this set of miRNAs target a
particular mRNA. We investigated how much the ComiR score
combination of multiple targets contributes to the improved
performance over a naı¨ve combination of scores. Figure 4 shows
that considering miRNA expression through the FD score or
WSUM score always improves the SVM integration of any
combination of target finders, although the degree of improvement
depends on the particular tool combination and the dataset used.
In all three datasets the performance of the SVM with the
improved combined scores of PITA, miRanda and TargetScan
(PMT in Figure 4) is almost as good as the SVM with all four
algorithms (Figure S6). The smallest improvement the ComiR
score offers is for the TargetScan/mirSVR combination. Also, in
the Drosophila external dataset, the ComiR score combination
Figure 2. ComiR schema.
doi:10.1371/journal.pcbi.1002830.g002
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substantially improves the performance of most dual tool
combinations (except TargetScan/mirSVR) and all the 3- and 4-
tool combinations. In the human PAR-CLIP dataset we see that in
general when scores are combined with the naı¨ve model,
TargetScan has the best performance, followed by mirSVR,
PITA and miRanda. However, with the ComiR model for
incorporation of miRNA expression (FD score or WSUM score)
PITA and miRanda become better than mirSVR. Finally, in all
datasets we see that the improvement of prediction accuracy is
higher when the FD score is used (i.e., for of PITA and miRanda)
than when the WSUM score is used (TargetScan and mirSVR).
This indicates that the Fermi-Dirac model is indeed more accurate
representation of the binding dynamics of miRNA:mRNA
targeting, thus bringing the efficiency of PITA and miRanda
closer to that of TargetScan and mirSVR. All the above indicate
that incorporating miRNA expression in general and the Fermi-
Dirac model in particular offer a very efficient way for combining
individual target scores compared to the naı¨ve model.
ComiR predicts that rs17737058 disrupts an interaction
critical for bone mineral density
The importance of the estrogen signaling, through the estrogen
receptor a (ERa) pathway in bone maintenance is well established
Figure 3. Predicting efficiency of Drosophila-trained ComiR on various datasets. (A) Self-test on the Drosophila Ago1-IP dataset consist of
Set I (positive examples) and equal number of negative examples (from Set IV). (B) Performance on an external Drosophila Ago1-IP dataset consisting
of Set III (positive examples) and the remaining of Set IV (negative examples). This Drosophila dataset was not used in training ComiR. (C) SN vs.
threshold on an external C. elegans AIN-IP dataset (not an ROC curve due to inability to define a negative dataset). (D) Performance on an external
human PAR-CLIP dataset. In all cases, TargetScan was used without the evolutionary conservation feature resulting in a binary outcome. For the
human dataset the reader can find a continuous TargetScan ROC curve in Figure S3B, plotted using the context score.
doi:10.1371/journal.pcbi.1002830.g003
ComiR: Combinatorial Modeling of miRNA Targeting
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[35–38]. We asked the question whether ComiR could be applied
to nine ERa pathway genes (Table S4) to identify SNPs in miRNA
binding which could be associated with altered bone mineral
density (BMD). Using dbSNP, we identified a total of 218 known
SNPs in their 39UTRs, 15 of which have minor allele frequency
(MAF) greater than 10% (Table S4). There are about 400,000
SNP:miRNA pairs and nearly 29,000 of them correspond to the
15 SNPs with MAF.0.1. We ranked the SNP:miRNA pairs based
on the SNP induced change in ComiR binding probability score.
We wanted to focus on high confidence targets (those with high
binding probability), so we used Eq. 4 for the ranking.
DPComiR~PComiR(wt):(PComiR(wt){PComiR(SNP)) ð4Þ
Out of the ,29,000 SNP:miRNA pairs we analyzed (those
corresponding to the 15 SNPs of Table S4), 52 had
DPComiR.0.01, with the miR-488-5p/rs17737058 (NCOA1) pair
having the highest PComiR(wt) probability score among them.
Importantly, rs17737058 is located in the center of the region
matching the miR-488-5p seed sequence (Figure S7). We validated
the effect of this SNP in the binding activity of miR-488-5p by first
overexpressing a miR-488-5p mimic or mimic negative control
(MNC) in U2OS-ERa cells and examining NCOA1 protein levels.
Overexpression of miR-488-5p resulted in ,50% relative
reduction of NCOA1 levels (Figure 5A). As expected, no change
was seen for NCOA3, a highly similar family member of NCOA1
that does not harbor a miR-488-5p target site (Figure 5A). Next,
we examined if rs17737058 is sufficient to disrupt this regulation.
Either the WT or rs17737058 39UTR of NCOA1 was cloned
downstream of the renilla luciferase CDS in the psiCHECK2
vector (Figure S8). The WT or SNP psiCHECK2 constructs were
co-transfected with either an MNC or miR-488-5p. Consistent
with the protein knockdown, WT renilla levels were reduced by
,50% after overexpression of miR-488-5p (compared to MNC)
Figure 4. Comparison of SVM models for multiple miRNA targets. Multiple miRNA target scores are combined using the naı¨ve model (red dots) or
the ComiR model (FD score or WSUM score). The comparison has been performed on the same datasets as in Figure 3 with the exception of the C.
elegans dataset, which has no proper ROC curve. Results are arranged by the difference the ComiR combination models offers over the naı¨ve
combination model. P: PITA, M: miRanda, T: TargetScan, S: mirSVR. AUC: area under the curve.
doi:10.1371/journal.pcbi.1002830.g004
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(Figure 5B). However, SNP renilla showed a 30% attenuated miR-
488-5p effect (Figure 5B). This indicates that the rs17737058 is
sufficient to partially block the regulation of NCOA1 by miR-488-
5p.
Since NCOA1 is known to modulate the estrogenic effect in
bone, we further investigated the role of this SNP in osteoporosis
by examining existing GWAS data. While rs17737058 is not
present in most SNP-chips, three other SNPs in the same linkage-
disequilibrium (LD) block (rs719189, rs2083389, and rs9309308)
are represented on the Affymetrix 100k SNP-chip used in the
Framingham Heart Study bone mineral density (BMD) genome-
wide association study. All three SNPs are significantly associated
with decreased BMD specifically in women (Table S5), but not at
genome-wide significance levels so they were not included in the
original publication [39]. To assess further the association between
these SNPs and BMD, we genotyped for three of these NCOA1
SNPs in an independent patient cohort. We utilized germline
DNA from a prospective clinical trial (COBRA) in which BMD
was measured as part of a comprehensive phenotype character-
ization [40–42]. In support of the GWAS studies, we detected
significant association between the three NCOA1 SNP and
decreased BMD in premenopausal women (Figure 5C). In
postmenopausal women (excluding patients taking bisphospho-
nates for treatment of osteoporosis as potential cofounding factor),
we observed the same trend although it did not reach significance.
Interestingly, examination of the postmenopausal women revealed
that SNP carriers were more likely than expected to have been on
bisphosphonates at the time of study (Table S6) suggesting that
Figure 5. rs17737058 is sufficient to disrupt miR-488-5p targeting of NCOA1 (SRC-1) and it associates with BMD. (A) Western blot of
U2OS-ERa cells were transfected with either a mimic negative control (MNC) or a miR-488-5p mimic miRNA. NCOA3 was used as a negative control
and b-tubulin as a loading control. (B) U2OS-ERa cells were transfected with 100 nm of MNC or miR-488-5p mimic with 500 ng of either WT or SNP
(rs17737058) psiCHECK2-renilla-NCOA1 39UTR in combination with MNC or miR-488-5p miRNA renilla luciferase values were normalized to firefly
luciferase values. * represents p,0.05 by t-test. (C) Premenopausal women not receiving bisphosphonates or chemotherapy (known role on BMD) in
the COBRA trial were genotyped for association with decreased BMD. * p-values,0.05 comparing WT and Het+Homo BMD for each genotype by t-
test.
doi:10.1371/journal.pcbi.1002830.g005
ComiR: Combinatorial Modeling of miRNA Targeting
PLOS Computational Biology | www.ploscompbiol.org 8 December 2012 | Volume 8 | Issue 12 | e1002830
women with this SNP may have an increased risk of loss of BMD.
A likely explanation of these data is that SNP carriers may
experience premature bone loss before menopause that is less
evident after menopause onset. This may be due to the underlying
function of NCOA1 as a coactivator of ERa and therefore the
phenotypes may be more pronounced in the presence of estrogen.
Together these data indicate that rs17737058 can be associated
with decreased BMD likely through the disruption of miR-488-5p
regulation of NCOA1. However, further experimentation with
animal models is required to prove this association. Thus, we
showed that applying ComiR to the ER pathway resulted in the
identification of a SNP in a miRNA:mRNA pair with clinical
significance in hormone response in bone.
Discussion
In this study we presented a new method that advances the
miRNA target prediction field in two key areas. One, it considers
the quantitative effect of miRNA expression in target occupancy
using a new thermodynamic model; and two, it quantitatively
evaluates and combines the effect of target sites of multiple
miRNAs on a given mRNA. We showed that our methodology
improves the efficiency of popular target prediction algorithms as
well as the overlap of their target datasets. Combining these
improved predictions in a single probabilistic score (via SVM
methodology) resulted in a new algorithm, ComiR, which when
trained on Drosophila AGO1-IP data, it efficiently predicted
targets of the differentially expressed set of miRNAs in Drosophila,
C. elegans and human.
By design, ComiR models the combinatorial effect of multiple
miRNAs on a given mRNA. Thus, we expect that it will perform
better in real-life examples, where multiple miRNAs are differen-
tially expressed between two conditions. It is noteworthy that
ComiR was proven to be more sensitive than any single tool. We
attribute this to the nature of the SVM and the ComiR scoring
system, which can elevate the targeting potential of a moderate
affinity target predicted by any given tool if the miRNA is
expressed in very high levels or if the mRNA contains multiple
targets of this miRNA. Interestingly, TargetScan performed better
than the other three algorithms and was competitive to ComiR on
the single plotted point. However, ComiR remained the best of the
algorithms tested. In addition, without evolutionary conservation
TargetScan returns a binary outcome (target/no target) that does
not allow for a threshold choice or for a scoring-based ranking of
SNPs. The only exception is the human targets, where it provides
a context score, which takes into consideration various features. Even
in this case, ComiR was significantly more accurate in the human
CLIP data and its better performance in terms of AUC was mostly
in the region of high to medium false positive rate (Figure S3B). In
any case, given the recent challenges of the assumption of
evolutionary conservation of miRNA genes [43,44] and their
targets [45], methods that do not depend on evolutionary
conservation may be proven a nice complement to the existing
methods that do. Finally, in the high sensitivity area all algorithms
seem to perform similarly, especially TargetScan and mirSVR.
Notably, the SVM combination of TargetScan and mirSVR has
the smallest improvement of ComiR vs. naı¨ve combination of
targets on this and the external Drosophila dataset (Figure 4).
Silencing of miRNAs is usually considered a milder perturba-
tion in the cell than the one caused by transfection, because the
transfected miRNAs that are introduced en masse in the cell create
a challenge to the capacity of the miRNA loading machinery [30].
There are currently no data to facilitate modeling of the miRNA
affinity to the mRISC complex. So, although the transfection
experiments were not the ideal test bed for ComiR, it was still
proven to be more sensitive than the other four algorithms.
We also showed that the ComiR score could be used to predict
the effect of SNPs in single miRNA targets. Ideally, SNP and
miRNA expression information should be obtained from the same
individuals. We expect that such data will be routinely collected in
the future. As a test case in this paper we analyzed the 39UTR
SNPs reported in dbSNP for the ERa pathway genes without
having the benefit of knowing the miRNA expression levels. Based
on ComiR top prediction, we postulated that miR-488-5p
regulates NCOA1 and that rs17737058 reduces this regulatory
effect. Since NCOA1 has a known role in maintaining BMD
[35,36,38], we examined rs17737058 for an effect on BMD.
Indeed, we found that this SNP was significantly associated with
decreased BMD in two independent datasets. These results are
strengthened by the observation that postmenopausal women
carrying the SNP are more likely to be prescribed bisphosphonates
than expected. This represents a rarely found example of a SNP
disrupting a miRNA target site that results in a verified clinical
phenotype. Interestingly, the clinical effect seems to be most
evident in premenopausal women. We note that the FHS study
was composed of two cohorts: the ‘Original Cohort’ (n = 159
women, mean age 77.5) and the ‘Offspring Cohort’ (n = 487
women, mean age 58.5) and the latter had three times more
samples than the former. The other sub-studies within the
osteoporosis GWAS meta-analysis [46] focused on older individ-
uals, which might explain the failure to detect this association.
Regardless, our data suggest that this SNP may identify
premenopausal women at risk of osteoporosis and it should be
considered a top candidate for further study and future
development of personalized medicine therapeutic approaches.
This is an important application of ComiR, because the
identification of DNA sequence variants with a mechanistic
functional role is becoming essential for the development of
personalized medicine strategies.
Notably, PITA and miRanda ranked the SNP very far down the
list (their score didn’t practically change between wild-type and
SNP sequence), mirSVR did not predict the pair, and TargetScan
predicted the change but it offered no ranking. So, although in this
case the lack of appropriate data did not allow us to take
advantage of the full ComiR capabilities, it still provided a
straightforward quantitative way to rank the SNPs affecting
miRNA:mRNA interactions. We expect that in the future, when
genotype and gene and miRNA expression data will be routinely
collected from the same individuals, ComiR will be invaluable in
identifying and ranking germline SNPs and somatic mutations that
are associated to the disease.
In summary, ComiR, the novel miRNA target prediction
method we presented here, solves two important problems that
hinder miRNA target prediction and offers a quantitative way to
rank SNPs associated to miRNA binding. To our knowledge, this
is the first algorithm that models the detailed thermodynamic
interactions of miRNA binding dynamics in a cell and incorpo-
rates the quantitative effect of miRNA expression on multiple
targets of multiple miRNA genes on the same mRNA. ComiR is
by no means perfect. miRNA targeting is a complicated procedure
and many characteristics still remain unknown. mRNA cellular
localization or association with various RNA-binding proteins may
influence miRNA binding. Interplay between miR-328 and RNA
binding proteins has been previously reported [47], but the data
are still scarce to allow for efficient modeling. RNA folding can
also play an important role in miRNA targeting as it appears to do
in other biological phenomena [48]. New high-throughput
datasets will become available in the future and help elucidate
ComiR: Combinatorial Modeling of miRNA Targeting
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these interactions. In that respect, ComiR is the first step towards a
more complete modeling of miRNA:mRNA interactions, which is
expected to be improved further as more types of high-throughput
data become available.
Materials and Methods
Training and test data sets
39UTR sequences. All the 39UTR sequences used to
implement our algorithm were selected from Ensembl.org. When
the database contains more than one 39UTR sequence for the
same Ensembl ID, the longest sequence was selected. We
considered only the 39UTR sequences with at least 50 bases. In
Table S7 we summarize the total number of genes and miRNAs
considered for each analyzed species.
Drosophila melanogaster training and test data set. The
primary data for the training set was obtained from the recent
study [22]. Briefly, the authors performed an improved Ago1 IP
protocol, identifying hundreds of miRNA targets in S2 cells of
Drosophila melanogaster (fly). The resultant Ago1 IP data was
compared with Ago1 depletion experiments [49] and less than
1/3 overlap was found between the mRNAs identified by the two
experiments. Consequently, they divided mRNAs in the four sets
schematized in Table S8. Set I is our positive training set
consisting of 142 mRNAs who were bound to Ago1 and up-
regulated following Ago1 depletion. Set IV contained the negative
examples, consisting of the mRNAs that were not bound to Ago1,
their expression remained unchanged following Ago 1 depletion,
and have no predicted target sites [22,50]. From Set IV we
selected the 142 most highly expressed mRNAs to be our balanced
negative training set. The identities and the expression values of
the 28 miRNAs that had at least 50 reads in the S2 cells [23] were
used in the ComiR input. The mRNA test set was composed of
Set III, as positive examples, and the remaining genes in Set IV
as negative examples. These datasets are not expected to be
perfect positive or negative datasets. For example, Set III will
contain mRNAs that were bound to Ago at low (undetectable)
levels; but it will also contain secondary affected mRNAs (e.g.,
targets of TFs that were targeted by miRNAs). Also, the remaining
Set IV genes are expressed at lower levels than those in the
training set. For those reasons we expect this testing set to be
noisier, but it is the best available we have to an external dataset.
C. elegans AIN IP test set. In Ref. [51], the authors use
AIN-1 and AIN-2 IP in a mixed stage population of C. elegans
followed by microarray analysis to identify potential miRNA
targets. To test our approach on a C. elegans data set, we considered
the list of 49 miRNA expressed with at least 50 reads in the cells
[51] and the lists of mRNAs that were IP enriched in AIN-1 and
AIN-2 IP. We use, as positive test set, the list of 568 39UTRs of
genes that were enriched in both AIN-1 and AIN-2 IP (set AIN1
and AIN2). Zhang et al. [51] only list the IP enriched mRNAs in
AIN-1 and AIN-2 IP, so there is insufficient information to
construct a negative test set with available data.
H. sapiens PAR-CLIP test set. Hafner et al [25] have
published a PAR-CLIP (Photoactivitable-Ribonucleoside-En-
hanced Crosslinking and Immunoprecipitation) dataset. RNA-
binding proteins (RBPs) or ribonucleoprotein complexes (RNPs)
were isolated in human embryonic kidney 293 cells (hek293). To
facilitate crosslinking, transcripts of cultured cells were incorpo-
rated with 4-thiouridine (4SU) and RNA bound RBP binding sites
were recorded by scoring for thymidine (T) to cytidine (C)
transitions in the sequenced cDNA [25]. Region of about 41 nt,
centered over these predominant T to C transitions were
extracted. These Crosslink-Centered Regions (CCRs) constituted
of clusters formed by at least 5 PAR-CLIP sequence reads and
contained more than 20% T to C transitions [25]. To obtain
evidence that CCRs contain functional miRNA binding sites, they
blocked the 27 top expressed miRNAs in hek293 cells, and
measured the change in mRNA expression.
We constructed our positive test set by considering all the 591
genes with at least one CCR located in the 39 UTR of the gene
and with a fold change after the 27 miRNA knockdown greater
than 0.1. We only considered those genes for which 39UTR
sequence is available. We constructed the corresponding negative
test set by choosing the same number of genes within the genes
without CCRs lying in the 39 UTR sequence, taking the ones with
the highest average expression in untreated hek293 cells.
Human let-7d and/or miR-30b transfection. Human fetal
lung fibroblasts (Lonza) were transfected with 100 nM let-7d
precursor and/or miR-30b precursor (Ambion, Austin, TX). The
results were compared to transfections with a negative control.
24 hours after transfection, RNA was isolated with the miRNeasy
mini kit (Qiagen, Valencia). RNA quantity and quality were
determined by NanoDrop and by Bioanalyzer (Agilent Technol-
ogies). Labeling was performed using the Agilent Low RNA Input
Linear Amplification Kit PLUS, one color (5184–3523, Agilent
Technologies) as per the manufacturer’s instructions. Briefly,
double-stranded cDNA was synthesized with an oligo(dT) primer,
which later acts as a template for cRNA synthesis using T7 RNA
polymerase. After verifying labeling efficiency, the Cy3 labeled
cRNA was hybridized onto Agilent Whole Human Genome
4644K arrays (G4112F, Agilent Technologies), with five replicates
per each condition, washed and scanned using Agilent Microarray
Scanner. Data files were obtained using Agilent Feature Extrac-
tion software version 9.5.3, data was cyclic lowess normalized and
differentially expressed genes were identified using Significance
Analysis of Microarrays (SAM) (http://www-stat.stanford.edu/
,tibs/SAM). A q-value of 5 that corresponds to a false discovery
rate (FDR) of 5% was set as the threshold for significance.
ComiR application in identifying disease-related SNPs
SNPs in estrogen receptor (ER) pathway genes. SNPs in
the 39UTR sequence of NCOA1 were downloaded from the
dbSNP database (human build 135) (Table S4). We considered the
reference 39UTR sequence (ref sequence) and 39UTR containing
each of the SNPs as separate sequences (SNP sequence). Each of
these was analyzed with ComiR for potential binding differences
for each of the known human miRNA genes (miRBase v. 18).
Assessing the effect of rs17737058 in miRNA
targeting. To ensure that NCOA1 is indeed a target of miR-
488-5p we overexpressed a miR-488-5p mimic to observe any
changes in NCOA1 protein levels. The U2OS estrogen receptor-a
stably transfected osteosarcoma cell line (U2OS-ERa: previously
described, see [52–54]) were cultured in DMEM/F12 phenol red-
free medium in 10% CSS and transfected with 50 nM of either a
miRNA mimic negative control (MNC: CN-001000-01, Dharma-
con) or a miR-488-5p mimic (488*: C-300748-05, Dharmacon)
using Lipofectamine 2000 (Invitrogen) following the manufactur-
er’s instructions. At ,48 h following transfection, cells were
harvested for western blot analysis. Antibodies used are as follows:
anti-SRC-1 (128E7) (Cell Signaling: 2191S) and anti-a-tubulin
(Sigma: T9026). To establish that rs17737058 is sufficient to
disrupt miR-488-5p regulation of NCOA1 the wild-type 39UTR
of NCOA1 was cloned from MCF-7 cells to the multiple cloning
site 39 of renilla in the psiCHECK2 vector. Importantly, firefly
luciferase is included in this vector under a separate promoter/
polyA site and was used as a transfection control. Site directed
mutagenesis was performed to generate the rs17737058 SNP
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construct. U2OS-ERa cells were transfected with 500 ng of either
WT or SNP version of this construct with 100 nM of either a
MNC or miR-488-5p mimic miRNA using Dharmafect Duo
transfection reagent following the manufacturer’s instructions.
Cells were lysed ,36 hours post-transfection and renilla/firefly
luciferase activity was measured using the Dual Luciferase Assay
System (Promega). Renilla activity was normalized to firefly
luciferase.
Association of rs17737058 with decreased BMD. Since
rs17737058 is not represented on most SNP-chips, we identified its
linkage-disequilibrium (LD) block using HapMap-CEU data in the
Genome Variation Server (GVS). This revealed a block of 28
SNPs in high LD with rs17737058. Three of these SNPs
(rs2083389, rs719189, and rs9309308) are represented on the
Affymetrix 100k SNP-chip used in the Framingham Heart Study
(FHS) bone mineral density (BMD) study [39] downloaded from
The Database of Genotype and Phenoptypes (dbGaP). Within this
dataset, all SNPs specifically within NCOA1 (n = 7) were
examined for an association with decreased BMD. Three of these
SNPs were then genotyped with predesigned Taqman assays
(Applied Biosystems) using germline DNA from a prospective
tamoxifen breast cancer clinical trial, through the Consortium on
Breast Cancer Pharacogenomics (COBRA) previously described
(www.ClinicalTrials.gov; NCT0022893) [40]. This trial was
designed to measure the effects of tamoxifen on various surrogates
of estrogen activity. Only the baseline BMD tests performed before
the administration of tamoxifen were used for the verification
analysis. BMD was measured by standard dual-energy X-ray
absorptiometry (DXA) scans, and the data have been deposited on
http://www.pharmgkb.org with the accession ID PS207749 [55].
Data access
The microarray data described in this work are deposited in the
Gene Expression Omnibus database (GEO acc no.: GSE38530). A
public web server for ComiR is available from the laboratory’s
web page: http://www.benoslab.pitt.edu/comir/.
Supporting Information
Figure S1 Distributions of the number of binding sites
identified on downregulated genes in the transfection
and co-transfection experiments. Binding sites identified on
genes downregulated only in the miR-30b transfection (red bars),
only in the let-7d transfection (yellow bars), only in the co-
transfection experiment (black bars), or in all three experiments
(green bars).
(PDF)
Figure S2 Species-specific score characteristics of four
target prediction tools. Density distribution of (A) the binding
energy of all the binding sites as calculated with miRanda, (B) the
interaction energy (ddG) os all the binding sites as calculated by
PITA, (C) all the mirSVR scores of the conserved predicted target
sites, and (D) the number of binding sites predicted by TargetScan.
Red: D. melanogaster; green: C. elegans; blue: H. sapiens.
(JPG)
Figure S3 Additional ROC curves. (A) Leave-one-out-cross-
validation (LOOCV) for the Drosophila AGO1 IP training dataset
and (B) ROC curves include the context score of TargetScan for the
human CLIP data.
(PDF)
Figure S4 Precision-recall curves for the three datasets.
Results presented for the two Drosophila AGO1 IP datasets (self-
test and external dataset) and the independent human PAR-CLIP
dataset plotted in Figure 3. The C. elegans dataset was omitted since
it did not have negative examples.
(PDF)
Figure S5 Analysis of the PAR-CLIP CCR data. ECDF of
the change in expression after blocking the top 27 miRNAs of the
mRNAs containing at least one CCR in the 39 UTR sequence.
Predictions are made by restricting the binding site searching on
the CCR sequences. Lower deciles refer to higher probability to be
a target. Genes are grouped in deciles respect to (A) ComiR with
normalized scores, (B) ComiR with scores normalized by mean,
(C) miRanda, and (D) PITA target prediction scores. In case of (E)
mirSVR scores and (F) TargetScan scores, genes are divided in
two groups, i.e. genes with and without seed’s matching.
(PDF)
Figure S6 Comparison of SVM models for multiple
miRNA targets. Multiple miRNA target scores are combined
using the naı¨ve model (red dots) or the ComiR model (FD score or
COMB score). The comparison has been performed on the same
datasets as in Fig. 3 with the exception of the C. elegans dataset,
which has no proper AUC curve. The tool combinations are
ordered by ComiR score combination performance. P: PITA, M:
miRanda, T:TargetScan, S: mirSVR. AUC: area under the curve.
(PDF)
Figure S7 Linkage disequilibrium in NCOA1 reveal
potential function SNP driving BMD association. Linkage
disequilibrium (LD) r2 values were calculated using HapMap-CEU
data using the Genome Variation Server (GVS). Arrows represent
the two SNPs (rs719189, rs2083389) associated with decreased
BMD in the FHS study. SNPs are arranged by LD bins
represented by solid black horizontal lines. Both rs719189 and
rs2083389 are found in the same LD bin with an additional 20
other SNPs at an average frequency of 21%. SNP rs number in
green: synonymous, orange: 39UTR. * represent SNPs where r2
values for all SNPs within a given bin are greater than 0.8.
(PDF)
Figure S8 Renilla luciferase construct. NCOA1 39UTR
was cloned into psiCHECK2 behind the renilla CDS.
(PDF)
Table S1 Regression Coefficient resulting from a back-
ward elimination of coefficient in the regression equa-
tion. The ‘‘selected genes’’ set contains the genes that were down
regulatedin the co-transfection experiment (miR-30b and let-7d)
only, and not in the single transfection experiments. NC = not
calculated (because eliminated from the model).
(XLSX)
Table S2 PAR-CLIP H.sapiens ecdf analysis details. For
each considered target prediction tool (ComiR, miRanda, PITA,
TargetScan and mirSVR) we report the mean, the standard
deviation of the mean (sdm), the number of genes, the pvalue
(pKS) and D value (dKS) of the KS test, and the W rank test
pvalue (pW) of each decile (or group) of genes. Genes containing
CCRs in the 39UTR sequence are grouped by deciles with respect
to their binding score for the considered target prediction tool. KS
test and W rank test are performed by comparing each decile or
group of genes with the reference set composed by genes that don’t
contain CCR in the 39UTR sequence. Columns B–F contain
results obtained by restricting the binding site search on CCR.
Columns G–K contain the results obtained by analyzing the
complete 39UTR sequence.
(XLSX)
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Table S3 Comparison of ComiR to TargetScan and
PITA on the let-7d/miR-30b transfection and co-trans-
fection datasets. Performance was measured on the set of
down-regulated genes in each experiment.
(XLSX)
Table S4 Information about SNPs examined as poten-
tially altering miRNA targets. ER pathway genes, number of
SNPs in their 39UTRs and common SNPs detected in their
39UTRs. MAF: Minor Allele Frequency (as reported in dbSNP
NCBI database)
(XLSX)
Table S5 SNPs in NCOA1 associate with decreased
BMD. Due to the known role of NCOA1 in maintaining bone
mineral density, data from the Framingham Heart Study (FHS)
bone mineral density study was specifically examined for NCOA1
SNP associations with decreased BMD. Shown in the table are 2/
6 SNPs within NCOA1 that show significant association with
decreased BMD by either Familial Based Association Testing
analysis (FBAT) or by Generalized Estimating Equations (GEE).
P-values shown have been Bonferroni adjusted for 6 tests (based on
6 SNPs in NCOA1 represented in the SNP-chip used in this
study). Other SNPs in NCOA1 not associated with decreased
BMD and their MAFs are: rs2165739 (0.50), rs6724282 (0.05),
rs6759706 (0.06), rs1992499 (0.4). MAF: minor allele frequency.
(XLSX)
Table S6 Postmenopausal NCOA1 SNP carriers are
more likely to be treated with bisphosphonates. At time
of study, more postmenopausal women with rs17737058 were
found to be on bisphosphonates than expected by chance. No
premenopausal women were on bisphosphonates at baseline.
Although no significant BMD difference was seen between WT/
SNP postmenopausal individuals, this is consistent with SNP
carriers having increased clinical indications for bisphosphonates.
(XLSX)
Table S7 Databases used and number of considered
genes.
(XLSX)
Table S8 Sets of genes detected by comparing AGO1 IP
and AGO1 depletion experiments. We include the number
of genes detected by Hong et al and the number of used 39UTR
sequences
(PDF)
Text S1 Detailed description of ComiR implementation
and other supporting information.
(PDF)
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